Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents

We report the first study of highly monodisperse and crystalline iron oxide nanocubes with sub-nm controlled size distribution (9.7 ± 0.5 nm in size) that achieve simultaneous contrast enhancement in both T1- and T2-weighted magnetic resonance imaging (MRI). Here, we confirmed the magnetite structur...

Full description

Bibliographic Details
Main Authors: Sharma, Vijay Kumar, Alipour, A., Soran-Erdem, Z., Aykut, Z. G., Demir, Hilmi Volkan
Other Authors: School of Electrical and Electronic Engineering
Format: Journal Article
Language:English
Published: 2016
Subjects:
Online Access:https://hdl.handle.net/10356/82700
http://hdl.handle.net/10220/40290
_version_ 1811690906007371776
author Sharma, Vijay Kumar
Alipour, A.
Soran-Erdem, Z.
Aykut, Z. G.
Demir, Hilmi Volkan
author2 School of Electrical and Electronic Engineering
author_facet School of Electrical and Electronic Engineering
Sharma, Vijay Kumar
Alipour, A.
Soran-Erdem, Z.
Aykut, Z. G.
Demir, Hilmi Volkan
author_sort Sharma, Vijay Kumar
collection NTU
description We report the first study of highly monodisperse and crystalline iron oxide nanocubes with sub-nm controlled size distribution (9.7 ± 0.5 nm in size) that achieve simultaneous contrast enhancement in both T1- and T2-weighted magnetic resonance imaging (MRI). Here, we confirmed the magnetite structure of iron oxide nanocubes by X-ray diffraction (XRD), selected area electron diffraction (SAED) pattern, optical absorption and Fourier transformed infrared (FT-IR) spectra. These magnetite nanocubes exhibit superparamagnetic and paramagnetic behavior simultaneously by virtue of their finely controlled shape and size. The magnetic measurements reveal that the magnetic moment values are favorably much lower because of the small size and cubic shape of the nanoparticles, which results in an enhanced spin canting effect. As a proof-of-concept demonstration, we showed their potential as dual contrast agents for both T1- and T2-weighted MRI via phantom studies, in vivo imaging and relaxivity measurements. Therefore, these low-magnetization magnetite nanocubes, while being non-toxic and bio-compatible, hold great promise as excellent dual-mode T1 and T2 contrast agents for MRI.
first_indexed 2024-10-01T06:11:26Z
format Journal Article
id ntu-10356/82700
institution Nanyang Technological University
language English
last_indexed 2024-10-01T06:11:26Z
publishDate 2016
record_format dspace
spelling ntu-10356/827002023-02-28T19:29:19Z Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents Sharma, Vijay Kumar Alipour, A. Soran-Erdem, Z. Aykut, Z. G. Demir, Hilmi Volkan School of Electrical and Electronic Engineering School of Physical and Mathematical Sciences Nanotechnology We report the first study of highly monodisperse and crystalline iron oxide nanocubes with sub-nm controlled size distribution (9.7 ± 0.5 nm in size) that achieve simultaneous contrast enhancement in both T1- and T2-weighted magnetic resonance imaging (MRI). Here, we confirmed the magnetite structure of iron oxide nanocubes by X-ray diffraction (XRD), selected area electron diffraction (SAED) pattern, optical absorption and Fourier transformed infrared (FT-IR) spectra. These magnetite nanocubes exhibit superparamagnetic and paramagnetic behavior simultaneously by virtue of their finely controlled shape and size. The magnetic measurements reveal that the magnetic moment values are favorably much lower because of the small size and cubic shape of the nanoparticles, which results in an enhanced spin canting effect. As a proof-of-concept demonstration, we showed their potential as dual contrast agents for both T1- and T2-weighted MRI via phantom studies, in vivo imaging and relaxivity measurements. Therefore, these low-magnetization magnetite nanocubes, while being non-toxic and bio-compatible, hold great promise as excellent dual-mode T1 and T2 contrast agents for MRI. ASTAR (Agency for Sci., Tech. and Research, S’pore) Published version 2016-03-15T08:41:56Z 2019-12-06T15:00:38Z 2016-03-15T08:41:56Z 2019-12-06T15:00:38Z 2015 Journal Article Sharma, V. K., Alipour, A., Soran-Erdem, Z., Aykut, Z. G., & Demir, H. V. (2015). Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents. Nanoscale, 7(23), 10519-10526. 2040-3364 https://hdl.handle.net/10356/82700 http://hdl.handle.net/10220/40290 10.1039/C5NR00752F en Nanoscale This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. 8 p. application/pdf
spellingShingle Nanotechnology
Sharma, Vijay Kumar
Alipour, A.
Soran-Erdem, Z.
Aykut, Z. G.
Demir, Hilmi Volkan
Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title_full Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title_fullStr Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title_full_unstemmed Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title_short Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1–T2 MRI contrast agents
title_sort highly monodisperse low magnetization magnetite nanocubes as simultaneous t1 t2 mri contrast agents
topic Nanotechnology
url https://hdl.handle.net/10356/82700
http://hdl.handle.net/10220/40290
work_keys_str_mv AT sharmavijaykumar highlymonodisperselowmagnetizationmagnetitenanocubesassimultaneoust1t2mricontrastagents
AT alipoura highlymonodisperselowmagnetizationmagnetitenanocubesassimultaneoust1t2mricontrastagents
AT soranerdemz highlymonodisperselowmagnetizationmagnetitenanocubesassimultaneoust1t2mricontrastagents
AT aykutzg highlymonodisperselowmagnetizationmagnetitenanocubesassimultaneoust1t2mricontrastagents
AT demirhilmivolkan highlymonodisperselowmagnetizationmagnetitenanocubesassimultaneoust1t2mricontrastagents